Pharmacokinetics of S-1 in cancer patients with renal dysfunction.

Trial Profile

Pharmacokinetics of S-1 in cancer patients with renal dysfunction.

Completed
Phase of Trial: Phase II

Latest Information Update: 28 Jan 2013

At a glance

  • Drugs Gimeracil/oteracil/tegafur (Primary)
  • Indications Cancer; Haematological malignancies; Solid tumours
  • Focus Pharmacokinetics
  • Most Recent Events

    • 28 Jan 2013 Status changed from not stated to completed as reported by University Hospital Medical Information Network - Japan record.
    • 21 Sep 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top